COMPARISON OF 3 DIFFERENT IMMUNOASSAYS FOR THE DETERMINATION OF CA 19-9 IN PANCREATIC CANCER PATIENTS - A NEW ASPECT OF POTENTIALLY CLINICAL RELEVANCE

被引：0
|
作者：
Klapdor, R. [1 ]
Bahlo, M. [1 ]
机构：
[1] ZeTDT GmbH, Internal Unit, Hamburg, Germany
来源：
ANTICANCER RESEARCH | 2014年 / 34卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
328
引用
收藏
页码：5998 / 5999
页数：2
相关论文
共 50 条
  • [21] Prognostic value of CA 19-9 in patients with pancreatic cancer treated with Gemcitabine
    Halm, U
    Schuhmann, T
    Keim, V
    Moessner, J
    GASTROENTEROLOGY, 1999, 116 (04) : A1129 - A1129
  • [22] CA 19-9 predicts resectability of pancreatic cancer even in jaundiced patients
    Santucci, Nicolas
    Facy, Olivier
    Ortega-Deballon, Pablo
    Lequeu, Jean-Baptiste
    Rat, Paul
    Rat, Patrick
    PANCREATOLOGY, 2018, 18 (06) : 666 - 670
  • [23] The Effect on Prognosis of Postoperative CA 19-9 Level in Patients With Pancreatic Cancer
    Kilickap, Saadettin
    Arslan, Cagatay
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (03): : 320 - 320
  • [24] RE: CA 19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Preoperative Therapy
    Bold, Richard J.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (07) : 2108 - 2110
  • [25] COMPARISON OF CA 19-9 AND TAG-72 EXPRESSION IN PANCREATIC-CANCER
    TEMPERO, M
    COLCHER, D
    TAKASAKI, H
    TAKIYAMA, Y
    SCHLOM, J
    POUR, PM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 385 - 385
  • [26] RE: CA 19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Preoperative Therapy
    Richard J. Bold
    Annals of Surgical Oncology, 2013, 20 : 2108 - 2110
  • [27] THE SEROLOGIC MARKER CA 19-9 AND PANCREATIC-CANCER
    NARDONE, DA
    ANNALS OF INTERNAL MEDICINE, 1989, 111 (02) : 184 - 185
  • [28] CA 19-9 serum course and prognosis of pancreatic cancer
    Safi, F
    Schlosser, W
    Falkenreck, S
    Beger, HG
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 1996, 20 (03) : 155 - 161
  • [29] CA 19-9 in pancreatic cancer - from diagnosis to therapy
    Rainer, Klapdor
    TUMOR BIOLOGY, 2006, 27 : 19 - 19
  • [30] CA 19-9 and Lewis Antigens in Pancreatic Cancer Reply
    Berger, Adam C.
    Hoffman, John P.
    Winter, Kathryn
    Regine, William
    Safran, Howard
    Abrams, Ross
    Willet, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) : 2573 - 2573
12345